Jacobs Bruce N.
Insider CIK 1821074 · KYMR Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-06-30 | 2026-07-02 | 61,378 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-30 | 2026-07-02 | 6,153 | $116.99 | $719.8K | 248,083 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-30 | 2026-07-02 | 3,200 | $117.70 | $376.6K | 244,883 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-30 | 2026-07-02 | 7,971 | $115.82 | $923.2K | 254,236 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-06-30 | 2026-07-02 | 61,378 | $5.33 | $327.1K | 321,992 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-30 | 2026-07-02 | 1,500 | $110.54 | $165.8K | 320,492 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-30 | 2026-07-02 | 1,700 | $111.57 | $189.7K | 318,792 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-30 | 2026-07-02 | 51,375 | $114.77 | $5.90M | 262,207 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-30 | 2026-07-02 | 4,110 | $114.19 | $469.3K | 313,582 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-06-30 | 2026-07-02 | 1,100 | $112.79 | $124.1K | 317,692 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-06-02 | 2026-06-03 | 12,653 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-06-02 | 2026-06-03 | 12,653 | $2.08 | $26.3K | 260,241 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2026-05-18 | 2026-05-19 | 15,000 | — | $0 | 12,653 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2026-05-18 | 2026-05-19 | 15,000 | $2.08 | $31.2K | 247,588 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-04 | 2026-03-04 | 2,519 | $85.04 | $214.2K | 234,472 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-04 | 2026-03-04 | 447 | $86.62 | $38.7K | 232,588 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-04 | 2026-03-04 | 492 | $84.00 | $41.3K | 236,991 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-04 | 2026-03-04 | 1,437 | $85.78 | $123.3K | 233,035 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2026-03-02 | 2026-03-04 | 35,300 | — | $0 | 35,300 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-02 | 2026-03-04 | 4,113 | $89.66 | $368.8K | 237,483 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-02 | 2026-03-04 | 1,424 | $88.50 | $126.0K | 241,596 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2026-03-02 | 2026-03-04 | 2,039 | $87.75 | $178.9K | 243,020 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award | 2026-03-02 | 2026-03-04 | 17,650 | — | $0 | 245,059 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-09-17 | 2025-09-17 | 42,246 | — | $0 | 27,653 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-09-17 | 2025-09-17 | 36,974 | — | $0 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-09-17 | 2025-09-17 | 79,220 | $50.00 | $3.96M | 227,409 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-09-17 | 2025-09-17 | 79,220 | $2.08 | $164.8K | 306,629 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-03-31 | 2025-04-01 | 25,000 | — | $0 | 69,899 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-03-31 | 2025-04-01 | 25,000 | $2.08 | $52.0K | 226,886 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2025-03-03 | 2025-03-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-03-03 | 2025-03-03 | 1,281 | $31.00 | $39.7K | 201,886 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2025-03-03 | 2025-03-03 | 5,754 | $30.33 | $174.5K | 203,167 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award | 2025-03-03 | 2025-03-03 | 30,000 | — | $0 | 208,921 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2025-01-10 | 2025-01-13 | 10,000 | — | $0 | 94,899 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2025-01-10 | 2025-01-13 | 10,000 | $2.08 | $20.8K | 178,921 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2024-06-27 | 2024-06-28 | 25,000 | — | $0 | 104,899 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2024-06-27 | 2024-06-28 | 25,000 | $2.08 | $52.0K | 168,554 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-04 | 2024-03-04 | 2,378 | $41.41 | $98.5K | 143,907 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-04 | 2024-03-04 | 1,301 | $42.39 | $55.1K | 142,606 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2024-03-04 | 2024-03-04 | 255 | $43.26 | $11.0K | 142,351 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2024-03-01 | 2024-03-04 | 187,500 | — | $0 | 187,500 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award | 2024-03-01 | 2024-03-04 | 31,250 | — | $0 | 146,285 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2023-06-02 | 2023-06-02 | 10,000 | — | $0 | 129,899 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2023-06-02 | 2023-06-02 | 10,000 | $2.08 | $20.8K | 115,035 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2023-03-02 | 2023-03-03 | 314 | $31.40 | $9.9K | 104,568 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2023-03-02 | 2023-03-03 | 1,056 | $30.88 | $32.6K | 104,882 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2023-03-01 | 2023-03-03 | 142,500 | — | $0 | 142,500 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award | 2023-03-01 | 2023-03-03 | 23,750 | — | $0 | 105,938 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2022-10-21 | 2022-10-24 | 10,000 | — | $0 | 139,899 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2022-10-21 | 2022-10-24 | 10,000 | $2.08 | $20.8K | 81,279 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2022-10-17 | 2022-10-17 | 10,000 | — | $0 | 149,899 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2022-10-17 | 2022-10-17 | 10,000 | $2.08 | $20.8K | 71,279 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2022-05-03 | 2022-05-03 | 20,000 | — | $0 | 159,899 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2022-05-03 | 2022-05-03 | 20,000 | $2.08 | $41.6K | 60,814 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award | 2022-03-01 | 2022-03-03 | 13,300 | — | $0 | 40,814 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2022-01-14 | 2022-01-14 | 10,000 | — | $0 | 179,899 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2022-01-14 | 2022-01-14 | 10,000 | $2.08 | $20.8K | 27,514 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2022-01-12 | 2022-01-14 | 15,000 | — | $0 | 36,974 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-01-12 | 2022-01-14 | 6,427 | $51.21 | $329.1K | 26,087 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2022-01-12 | 2022-01-14 | 15,000 | $2.08 | $31.2K | 32,514 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-01-12 | 2022-01-14 | 1,422 | $53.27 | $75.7K | 17,514 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2022-01-12 | 2022-01-14 | 7,151 | $52.13 | $372.8K | 18,936 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-12-03 | 2021-12-03 | 10,000 | — | $0 | 189,899 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-03 | 7,713 | $53.31 | $411.2K | 19,801 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-03 | 1,987 | $54.32 | $107.9K | 17,814 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-03 | 300 | $55.07 | $16.5K | 17,514 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-12-03 | 2021-12-03 | 10,000 | $2.08 | $20.8K | 27,514 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-11-23 | 2021-11-23 | 10,000 | — | $0 | 199,899 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-11-23 | 2021-11-23 | 10,000 | $2.08 | $20.8K | 17,256 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2021-09-03 | 2021-09-03 | 10,000 | — | $0 | 209,899 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-09-03 | 2021-09-03 | 10,000 | $2.08 | $20.8K | 17,256 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-09-03 | 2021-09-03 | 1,500 | $60.50 | $90.8K | 7,256 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-09-03 | 2021-09-03 | 8,500 | $60.05 | $510.4K | 8,756 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2021-06-03 | 2021-06-04 | 10,000 | — | $0 | 219,899 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-06-03 | 2021-06-04 | 4,494 | $47.13 | $211.8K | 7,256 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-06-03 | 2021-06-04 | 5,506 | $46.66 | $256.9K | 11,494 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-06-03 | 2021-06-04 | 10,000 | $2.08 | $20.8K | 17,256 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-04-13 | 2021-04-13 | 7,000 | — | $0 | 229,899 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-04-13 | 2021-04-13 | 7,000 | $2.08 | $14.6K | 7,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-03-15 | 2021-03-15 | 8,195 | — | $0 | 234,061 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-03-15 | 2021-03-15 | 8,195 | $60.17 | $493.1K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-03-15 | 2021-03-15 | 8,195 | $2.08 | $17.0K | 8,195 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-03-11 | 2021-03-15 | 1,805 | — | $0 | 242,256 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-03-11 | 2021-03-15 | 1,805 | $60.07 | $108.4K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-03-11 | 2021-03-15 | 1,805 | $2.08 | $3.8K | 1,805 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-03-08 | 2021-03-08 | 10,000 | — | $0 | 244,061 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-03-08 | 2021-03-08 | 1 | $52.15 | $52 | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-03-08 | 2021-03-08 | 10,000 | $2.08 | $20.8K | 10,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-03-08 | 2021-03-08 | 7,699 | $50.46 | $388.5K | 2,301 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-03-08 | 2021-03-08 | 2,300 | $51.28 | $117.9K | 1 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise deriv | 2021-03-03 | 2021-03-05 | 20,000 | — | $0 | 254,061 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-03-03 | 2021-03-05 | 6,881 | $44.12 | $303.6K | 13,119 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-03-03 | 2021-03-05 | 12,019 | $45.07 | $541.7K | 1,100 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | S Sale | 2021-03-03 | 2021-03-05 | 1,100 | $45.75 | $50.3K | 0 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | M Exercise | 2021-03-03 | 2021-03-05 | 20,000 | $2.08 | $41.6K | 20,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 140,000 | — | $0 | 140,000 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2020-08-20 | 2020-08-21 | 32,904 | — | $0 | 32,904 | SEC↗ |